B Uring-Lambert
Overview
Explore the profile of B Uring-Lambert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cotin G, Blanco-Andujar C, Nguyen D, Affolter C, Boutry S, Boos A, et al.
Nanotechnology
. 2019 Jun;
30(37):374002.
PMID: 31195384
Owing to the great potential of iron oxide nanoparticles (NPs) for nanomedicine, large efforts have been made to better control their magnetic properties, especially their magnetic anisotropy to provide NPs...
2.
Lambert C, Sarrat A, Bienvenu F, Brabant S, Nicaise-Roland P, Alyanakian M, et al.
Allergy
. 2014 Nov;
70(2):180-6.
PMID: 25394543
Background: Allergen-specific serum immunoglobulin E detection and quantification have become an important step in allergy diagnosis and follow-up. In line with the current trend of laboratory test accreditation to international...
3.
Renaud M, Aupy J, Uring-Lambert B, Chanson J, Collongues N, Blanc F, et al.
Eur J Neurol
. 2014 Apr;
21(6):901-6.
PMID: 24698178
Background And Purpose: Anti-β2-glycoprotein I (anti-β2-GPI) antibodies are part of the heterogeneous family of antiphospholipid antibodies and seem to be present in various neurological manifestations in addition to antiphospholipid syndrome...
4.
Wendt G, Kemmel V, Patte-Mensah C, Uring-Lambert B, Eckert A, Schmitt M, et al.
Neuroscience
. 2014 Jan;
263:203-15.
PMID: 24456637
Clinical observations suggested that gamma-hydroxybutyrate (GHB) protects nerve cells against death but the direct proofs are missing. Here, we combined several approaches to investigate GHB capacity to protect human neuroblastoma...
5.
Casset A, Marchand C, Purohit A, Le Calve S, Uring-Lambert B, Donnay C, et al.
Allergy
. 2006 Sep;
61(11):1344-50.
PMID: 17002712
Background: Formaldehyde, an indoor air pollutant, is known to be an irritant and an etiologic factor in occupational asthma. An epidemiologic study suggests that it may also increase the risk...
6.
Boeckler P, Meyer A, Uring-Lambert B, Goetz J, Cribier B, Hauptmann G, et al.
Clin Immunol
. 2006 Sep;
121(2):198-202.
PMID: 16987709
Introduction: Deficiencies in components of the classical pathway of complement activation are strong risk factors for lupus erythematosus (LE).Yet, it has not been addressed whether the conventional measurements of the...
7.
Casset A, Purohit A, Marchand C, Le Calve S, Donnay C, Uring-Lambert B, et al.
Rev Mal Respir
. 2006 Apr;
23(1 Suppl):3S25-34.
PMID: 16604011
Introduction: Formaldehyde is an ubiquitous indoor chemical polutant. Occupational exposure to high concentrations has revealed its irritant and allergenic potential. Nevertheless, domestic exposure to low concentrations may also have an...
8.
Boeckler P, Milea M, Meyer A, Uring-Lambert B, Heid E, Hauptmann G, et al.
Br J Dermatol
. 2005 Feb;
152(2):265-70.
PMID: 15727637
Background: Although deficiencies in the early components of the complement system were among the first identified genetic risk factors for systemic lupus erythematosus (SLE), only a few studies addressed their...
9.
Lipsker D, Uring-Lambert B, Meyer A, Hartmann D, Grosshans E, Hauptmann G
Arch Dermatol
. 2000 Dec;
136(12):1508-14.
PMID: 11115162
Background: The gene deletion responsible for the type I human complement C2 deficiency was reported in 1992. The purpose of our study is to evaluate clinical and immunological characteristics of...
10.
Chamouard P, Pencreach E, Maloisel F, Grunebaum L, Ardizzone J, Meyer A, et al.
Gastroenterology
. 1998 Dec;
116(1):144-8.
PMID: 9869612
Background & Aims: Despite extensive investigations of portal vein thrombosis, no underlying cause is identifiable in up to 30% of patients. A recently described mutation of the prothrombin gene at...